Exela Technologies Stock Forecast, Price & News

+0.04 (+1.94 %)
(As of 09/16/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume9.75 million shs
Average Volume32.69 million shs
Market Capitalization$302.49 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive XELA News and Ratings via Email

Sign-up to receive the latest news and ratings for Exela Technologies and its competitors with MarketBeat's FREE daily newsletter.

Exela Technologies logo

About Exela Technologies

Exela Technologies, Inc. (Exela), formerly Quinpario Acquisition Corp. 2, is engaged in providing information and transaction processing solutions. The Company’s segments include Information and Transaction Processing Solutions (ITPS), Healthcare Solutions (HS) and Legal & Loss Prevention Services (LLPS). ITPS provides industry solutions for banking and financial services, including lending solutions for mortgages, banking solutions for clearing, anti-money laundering, sanctions, cross-border settlement; property and casualty insurance solutions for enrollments, and communications. The HS segment offerings include integrated accounts payable and accounts receivable, and information management for both the healthcare payer and provider markets. The LLPS segment solutions include processing of legal claims for class action and mass action settlement administrations, involving project management support, notification and collection, analysis, and distribution of settlement funds.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

2.20 out of 5 stars

Business Services Sector

101st out of 391 stocks

Business Services, Not Elsewhere Classified Industry

45th out of 134 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Exela Technologies (NASDAQ:XELA) Frequently Asked Questions

Is Exela Technologies a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Exela Technologies in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Exela Technologies stock.
View analyst ratings for Exela Technologies
or view top-rated stocks.

What stocks does MarketBeat like better than Exela Technologies?

Wall Street analysts have given Exela Technologies a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Exela Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Exela Technologies?

Exela Technologies saw a drop in short interest in August. As of August 13th, there was short interest totaling 7,080,000 shares, a drop of 18.9% from the July 29th total of 8,730,000 shares. Based on an average daily trading volume, of 68,620,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 12.5% of the company's shares are short sold.
View Exela Technologies' Short Interest

When is Exela Technologies' next earnings date?

Exela Technologies is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.
View our earnings forecast for Exela Technologies

How were Exela Technologies' earnings last quarter?

Exela Technologies, Inc. (NASDAQ:XELA) issued its earnings results on Monday, August, 9th. The company reported ($0.33) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.45) by $0.12. The company had revenue of $293.01 million for the quarter.
View Exela Technologies' earnings history

How has Exela Technologies' stock been impacted by Coronavirus?

Exela Technologies' stock was trading at $0.6162 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, XELA shares have increased by 240.8% and is now trading at $2.10.
View which stocks have been most impacted by COVID-19

When did Exela Technologies' stock split? How did Exela Technologies' stock split work?

Exela Technologies's stock reverse split before market open on Tuesday, January 26th 2021. The 1-3 reverse split was announced on Monday, January 25th 2021. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 25th 2021. An investor that had 100 shares of Exela Technologies stock prior to the reverse split would have 33 shares after the split.

What guidance has Exela Technologies issued on next quarter's earnings?

Exela Technologies updated its FY 2021 earnings guidance on Tuesday, September, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.25 billion-$1.39 billion, compared to the consensus revenue estimate of $1.33 billion.

What price target have analysts set for XELA?

2 equities research analysts have issued 1-year price objectives for Exela Technologies' stock. Their forecasts range from $4.00 to $4.00. On average, they expect Exela Technologies' stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 90.5% from the stock's current price.
View analysts' price targets for Exela Technologies
or view top-rated stocks among Wall Street analysts.

Who are Exela Technologies' key executives?

Exela Technologies' management team includes the following people:
  • Suresh Yannamani, President (Age 51)
  • Ronald Clark Cogburn, Chief Executive Officer, Director (Age 61)
  • Jim Reynolds, Chief Financial Officer, Director (Age 48)
  • Mark Fairchild, President, Exela Enterprise Solutions (Age 57)
  • Shrikant Sortur, Executive Vice President - Global Finance (Age 44)
  • Joshua M. Black, Director (Age 30)
  • Par Chadha, Director (Age 62) (LinkedIn Profile)
  • Gordon J. Coburn, Director (Age 53)
  • Nathaniel J. Lipman, Director (Age 53)
  • Matthew H. Nord, Director (Age 38)

What is Ron Cogburn's approval rating as Exela Technologies' CEO?

140 employees have rated Exela Technologies CEO Ron Cogburn on Ron Cogburn has an approval rating of 46% among Exela Technologies' employees. This puts Ron Cogburn in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Exela Technologies' key competitors?

What other stocks do shareholders of Exela Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exela Technologies investors own include Biocept (BIOC), Acasti Pharma (ACST), Avinger (AVGR), Bionano Genomics (BNGO), Heat Biologics (HTBX), T2 Biosystems (TTOO), Onconova Therapeutics (ONTX), Outlook Therapeutics (OTLK), (SCON) and AgEagle Aerial Systems (UAVS).

What is Exela Technologies' stock symbol?

Exela Technologies trades on the NASDAQ under the ticker symbol "XELA."

Who are Exela Technologies' major shareholders?

Exela Technologies' stock is owned by many different institutional and retail investors. Top institutional investors include Monashee Investment Management LLC (5.07%), Vanguard Group Inc. (2.81%), Shay Capital LLC (1.34%), Alyeska Investment Group L.P. (1.20%), Goldman Sachs Group Inc. (1.04%) and EJF Capital LLC (0.84%). Company insiders that own Exela Technologies stock include Apollo Management Holdings Gp, and Par Chadha.
View institutional ownership trends for Exela Technologies

Which institutional investors are selling Exela Technologies stock?

XELA stock was sold by a variety of institutional investors in the last quarter, including Armistice Capital LLC, Alyeska Investment Group L.P., Susquehanna Fundamental Investments LLC, and Vanguard Group Inc..
View insider buying and selling activity for Exela Technologies
or view top insider-selling stocks.

Which institutional investors are buying Exela Technologies stock?

XELA stock was purchased by a variety of institutional investors in the last quarter, including Monashee Investment Management LLC, Shay Capital LLC, EJF Capital LLC, Goldman Sachs Group Inc., Morgan Stanley, Morgan Stanley, Susquehanna International Group LLP, and State Street Corp.
View insider buying and selling activity for Exela Technologies
or or view top insider-buying stocks.

How do I buy shares of Exela Technologies?

Shares of XELA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Exela Technologies' stock price today?

One share of XELA stock can currently be purchased for approximately $2.10.

How much money does Exela Technologies make?

Exela Technologies has a market capitalization of $302.49 million and generates $1.29 billion in revenue each year. The company earns $-178,530,000.00 in net income (profit) each year or ($3.66) on an earnings per share basis.

How many employees does Exela Technologies have?

Exela Technologies employs 19,000 workers across the globe.

What is Exela Technologies' official website?

The official website for Exela Technologies is

Where are Exela Technologies' headquarters?

Exela Technologies is headquartered at 2701 EAST GRAUWYLER ROAD, IRVING TX, 75061.

How can I contact Exela Technologies?

Exela Technologies' mailing address is 2701 EAST GRAUWYLER ROAD, IRVING TX, 75061. The company can be reached via phone at 844-935-2832 or via email at [email protected]

This page was last updated on 9/16/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.